Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Metabolic, Endocrine, and Central Effects of Genistein Aglycone in Glucocorticoid Induced Osteoporosis

NCT03040531 is registered in ClinicalTrials.gov with University of Messina as lead sponsor.

NCT NCT03040531
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03040531 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Metabolic, Endocrine, and Central Effects of Genistein Aglycone in Glucocorticoid Induced Osteoporosis
Lead sponsor
University of Messina
Phase
Phase 2/3
Overall status
Unknown status
Start date
January 19, 2017
Completion date
December 30, 2018
Enrollment
200 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

osteoporosis, steroid induced